Conference Coverage

VIDEO: Larger lentigo maligna lesions increase risk


 

AT NOAH 57

References

ASHEVILLE, N.C. – What are the risk factors for invasive melanoma in patients with lentigo maligna? Size, for one thing, according to Dr. Suzanne M. Olbricht.

In an interview at the annual meeting of the Noah Worcester Dermatological Society, Dr. Olbricht of the Lahey Hospital and Medical Center in Burlington, Mass., reviewed evidence suggesting that the recurrence rate is highest for large lesions. “This is important information that helps us think about the treatments we can use,” she said.

Dr. Olbricht had no financial conflicts to disclose.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

hsplete@frontlinemedcom.com

Recommended Reading

RNA sequencing characterized high-risk squamous cell carcinomas
MDedge Hematology and Oncology
MEK inhibitors can induce skin eruptions with distinctive duskiness
MDedge Hematology and Oncology
Handheld device illuminates possible routes of melanoma metastases
MDedge Hematology and Oncology
Teledermoscopy referrals surpass paper for managing skin cancer patients
MDedge Hematology and Oncology
Xerosis is significant risk during targeted anticancer treatments
MDedge Hematology and Oncology
Overall survival plateaus at 3 years for ipilimumab-treated melanoma patients
MDedge Hematology and Oncology
Melanoma incidence highest in Oregon, lowest in Texas in 2015
MDedge Hematology and Oncology
Laser-enhanced 5-FU scores with squamous cell, basal cell patients
MDedge Hematology and Oncology
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Hematology and Oncology
Melanoma incidence drops for U.S. children and teens
MDedge Hematology and Oncology